Day: November 24, 2022

Four adult cynomolgus monkeys were dosed i.v. clinical development. Key Results Antibody potency was improved 8600-fold, and the target affinity was reached. The refined model predicted pharmacodynamic effects at doses as low as 1 mg kg?1 and a study in cynomolgus monkeys confirmed efficacy at 1 mg kg?1 dosing. Conclusions and Implications This rational approach […]